Apomorphine tolerance in Parkinson's disease: Lack of a dose effect

Stephen T. Gancher, William Woodward, John Nutt

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

The development of tolerance to dopaminergic drugs may be important in the long-term therapy of Parkinson's disease. In this study, we sought to determine whether tolerance developed during infusions of apomorphine and if there was evidence of any dose dependency. Eight patients with Parkinson's disease received 4- to 6-h infusions of apomorphine at low, medium, and high rates on consecutive days. Before and after each infusion, test boluses of apomorphine were administered to measure sensitivity to the drug. The duration of motor effects after the postinfusion boluses were reduced in comparison to those of the preinfusion boluses, indicating that tolerance developed during the infusions. The infusion rate did not affect the responses to the postinfusion test boluses. Our observations indicate that tolerance develops to the antiparkinsonian effect of apomorphine after several hours of its constant infusion, but is not influenced by the dose of drug administered.

Original languageEnglish (US)
Pages (from-to)59-64
Number of pages6
JournalClinical Neuropharmacology
Volume19
Issue number1
StatePublished - 1996

Fingerprint

Apomorphine
Parkinson Disease
Antiparkinson Agents
Dopamine Agents
Pharmaceutical Preparations
Therapeutics

Keywords

  • Apomorphine
  • Parkinson's disease
  • Pharmacodynamics
  • Tolerance

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Clinical Neurology
  • Neuroscience(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Apomorphine tolerance in Parkinson's disease : Lack of a dose effect. / Gancher, Stephen T.; Woodward, William; Nutt, John.

In: Clinical Neuropharmacology, Vol. 19, No. 1, 1996, p. 59-64.

Research output: Contribution to journalArticle

@article{7296f153bd3c4f4199fbaacca3d3e971,
title = "Apomorphine tolerance in Parkinson's disease: Lack of a dose effect",
abstract = "The development of tolerance to dopaminergic drugs may be important in the long-term therapy of Parkinson's disease. In this study, we sought to determine whether tolerance developed during infusions of apomorphine and if there was evidence of any dose dependency. Eight patients with Parkinson's disease received 4- to 6-h infusions of apomorphine at low, medium, and high rates on consecutive days. Before and after each infusion, test boluses of apomorphine were administered to measure sensitivity to the drug. The duration of motor effects after the postinfusion boluses were reduced in comparison to those of the preinfusion boluses, indicating that tolerance developed during the infusions. The infusion rate did not affect the responses to the postinfusion test boluses. Our observations indicate that tolerance develops to the antiparkinsonian effect of apomorphine after several hours of its constant infusion, but is not influenced by the dose of drug administered.",
keywords = "Apomorphine, Parkinson's disease, Pharmacodynamics, Tolerance",
author = "Gancher, {Stephen T.} and William Woodward and John Nutt",
year = "1996",
language = "English (US)",
volume = "19",
pages = "59--64",
journal = "Clinical Neuropharmacology",
issn = "0362-5664",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Apomorphine tolerance in Parkinson's disease

T2 - Lack of a dose effect

AU - Gancher, Stephen T.

AU - Woodward, William

AU - Nutt, John

PY - 1996

Y1 - 1996

N2 - The development of tolerance to dopaminergic drugs may be important in the long-term therapy of Parkinson's disease. In this study, we sought to determine whether tolerance developed during infusions of apomorphine and if there was evidence of any dose dependency. Eight patients with Parkinson's disease received 4- to 6-h infusions of apomorphine at low, medium, and high rates on consecutive days. Before and after each infusion, test boluses of apomorphine were administered to measure sensitivity to the drug. The duration of motor effects after the postinfusion boluses were reduced in comparison to those of the preinfusion boluses, indicating that tolerance developed during the infusions. The infusion rate did not affect the responses to the postinfusion test boluses. Our observations indicate that tolerance develops to the antiparkinsonian effect of apomorphine after several hours of its constant infusion, but is not influenced by the dose of drug administered.

AB - The development of tolerance to dopaminergic drugs may be important in the long-term therapy of Parkinson's disease. In this study, we sought to determine whether tolerance developed during infusions of apomorphine and if there was evidence of any dose dependency. Eight patients with Parkinson's disease received 4- to 6-h infusions of apomorphine at low, medium, and high rates on consecutive days. Before and after each infusion, test boluses of apomorphine were administered to measure sensitivity to the drug. The duration of motor effects after the postinfusion boluses were reduced in comparison to those of the preinfusion boluses, indicating that tolerance developed during the infusions. The infusion rate did not affect the responses to the postinfusion test boluses. Our observations indicate that tolerance develops to the antiparkinsonian effect of apomorphine after several hours of its constant infusion, but is not influenced by the dose of drug administered.

KW - Apomorphine

KW - Parkinson's disease

KW - Pharmacodynamics

KW - Tolerance

UR - http://www.scopus.com/inward/record.url?scp=0030067273&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030067273&partnerID=8YFLogxK

M3 - Article

C2 - 8867518

AN - SCOPUS:0030067273

VL - 19

SP - 59

EP - 64

JO - Clinical Neuropharmacology

JF - Clinical Neuropharmacology

SN - 0362-5664

IS - 1

ER -